drugset / Trial / NCT03316378

Achilles Pain Block

NCT03316378

Phase 2/3 Completed 46 enrolled Ruth Chimenti
Non-randomizedSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to better understand how the peripheral and central nervous system interact to produce the sensation of pain and motor patterns in patients with achilles tendinopathy (AT). These findings will motivate the development of future clinical studies that incorporate knowledge about pain processing and movement strategies in patients with tendinopathy. Participants with achilles tendinopathy will receive an anesthetic injection to the achilles tendon in order to examine how reduced pain, detected by the peripheral nervous system, alters task performance and perception of pain. We hypothesize that there are factors within the central nervous system that contribute to continued pain and disability in patients with chronic AT.

Timeline

Start
2016-01-28
Primary completion
2018-05-10
Completion
2018-05-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified 0.5 % Subcutaneous
Subject Ropivacaine Other / unclassified 4 ml Subcutaneous

Indications